Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Autolus Therapeutics (AUTL) Gross Profit: 2016-2024

Historic Gross Profit for Autolus Therapeutics (AUTL) over the last 9 years, with Dec 2024 value amounting to -$1.3 million.

  • Autolus Therapeutics' Gross Profit rose 30.29% to -$7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.3 million, marking a year-over-year increase of 23.45%. This contributed to the annual value of -$1.3 million for FY2024, which is 174.62% down from last year.
  • Autolus Therapeutics' Gross Profit amounted to -$1.3 million in FY2024, which was down 174.62% from $1.7 million recorded in FY2023.
  • Autolus Therapeutics' 5-year Gross Profit high stood at $6.2 million for FY2022, and its period low was -$9.3 million during FY2020.
  • Moreover, its 3-year median value for Gross Profit was $1.7 million (2023), whereas its average is $2.2 million.
  • Its Gross Profit has fluctuated over the past 5 years, first spiked by 311.02% in 2022, then crashed by 174.62% in 2024.
  • Yearly analysis of 5 years shows Autolus Therapeutics' Gross Profit stood at -$9.3 million in 2020, then spiked by 116.16% to $1.5 million in 2021, then surged by 311.02% to $6.2 million in 2022, then plummeted by 72.59% to $1.7 million in 2023, then crashed by 174.62% to -$1.3 million in 2024.